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Abstract Previously, we observed that sustained activation




(NKCC) in C11 cells resembling intercalated cells from
collecting ducts of the Madin-Darby canine kidney. This
study examined the role of stress-activated protein kinases
(SAPK) in NKCC inhibition triggered by purinergic
receptors. Treatment of C11 cells with ATP led to sustained
phosphorylation of SAPK such as JNK and p38. Activation
of these kinases also occurred in anisomycin-treated cells.
Surprisingly, we observed that compounds SP600125 and
SB202190, known as potent inhibitors of JNK and p38 in
cell-free systems, activated rather than inhibited phosphor-
ylation of the kinases in C11 cells. Importantly, similarly to
ATP, all the above-listed activators of JNK and p38
phosphorylation inhibited NKCC. Thus, our results suggest
that activation of JNK and/or p38 contributes to NKCC
suppression detected in intercalated-like cells from distal









− cotransporter (NKCC), providing electroneutral




− and selectively inhibited by bumetanide
and other high-ceiling diuretics, belongs to the superfamily
of Cl
−-coupled monovalent cation cotransporters. Two
isoforms of this carrier have been cloned from vertebrate
cDNA libraries. A ubiquitous NKCC1 isoform is expressed
in all types of cells studied so far [1], including the
basolateral membrane of epithelial cells derived from
collecting ducts of the Madin-Darby canine kidney
(MDCK) [2]. This isoform contributes to cell volume
regulation, adjustment of [Cl
−]i above the values predicted
by Nernst equilibrium potential and transcellular movement
of salt and NHþ
4 in the secretory epithelium [1, 3]. Unlike
NKCC1, three alternatively spliced variants of the NKCC2
isoform were found exclusively on the apical membrane of
renal epithelial cells from the macula densa and thick
ascending limb of Henle’s loop. In the thick ascending
limb, NKCC2 plays a key role in bulk salt reabsorption [3],
whereas in the macula densa this carrier is involved in
sensing extracellular Cl
− concentration and regulating renal
function via tubuloglomerular feedback [4].
Because of compensatory reactions occurring in proxi-
mal segments via tubuloglomerular feedback, collecting
ducts are considered a major target for regulation of water/
salt and acid-base homeostasis by hormones and neuro-
transmitters, including vasopressin, bradykinin, atrial
natriuretic peptide, prostanoids, mineralocorticoids, and
catecholamines [5]. Under certain circumstances, extracel-
lular nucleotides, such as ATP, UTP, and ADP, can also
regulate renal epithelium function by activating two recep-
tor subtypes. P2Y receptors are coupled to heterotrimeric
G proteins and expressed in all types of renal cells studied
so far, whereas P2X receptors correspond to ligand-gated
cation channels, and their expression in the kidney is
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The renal ion transport systems affected by P2Y
receptors have been explored mainly in MDCK cells where
extracellular ATP leads to transient Cl
− secretion [11]. Two
populations of cells have been isolated from commercially
available stocks of MDCK cells: C7- and C11-MDCK cells
[12]. C7 cells have high transepithelial electrical resistance
(Rte), are peanut lectin negative, maintain pHi at 7.39, and
have large K
+ conductance, thus resembling principal cells
from the collecting ducts. C11 cells, on the other hand,
resemble intercalated cells; they have low Rte, are peanut
lectin positive, maintain pHi at 7.16, and have large Cl
− and
H
+ conductances [12]. We were the first to report that
transient activation of basolateral NKCC in ATP-treated C7
cells is evoked by elevation of [Ca
2+]i [13] and contributes
to transepithelial Cl
− secretion [14]. We also noted that in
contrast to C7 and other cells studied so far, sustained
application of ATP to C11 cells resulted in sharp inhibition
of this carrier [15] that was absent under the addition of
other modulators of transepithelial ion fluxes [16].
Several hypotheses might be proposed to explain the cell
type-specific impact of extracellular nucleotides on NKCC
activity. First, NKCC inhibition is mediated by the P2
receptor isoform whose expression is limited to intercalated
cells. However, in a recent study, we established that
NKCC inhibition in ATP-treated C11 cells is caused by
activation of P2Y1 receptors [13] whose expression has
been detected in most of the cell types studied so far,
including C7 cells [17]. Second, in intercalated cells,
sustained activation of P2Y1 receptors leads to inhibition
of the cell type-specific NKCC isoform. This hypothesis
contradicts data showing that prolonged exposure of C11
cell monolayers to ATP abolished the increment of
bumetanide-sensitive
86Rb uptake across the basolateral
membrane by transfection with human NKCC1 [18]. Third,
delayed NKCC1 inhibition seen in ATP-treated C11 cells is
mediated by the de novo expression of intercalated cell-
specific inhibitor(s) of this carrier. However, the inhibitory
action of ATP on NKCC activity in C11 monolayers was
preserved in the presence of inhibitors of RNA and protein
synthesis [18]. Fourth, NKCC1 inhibition is caused by the
intercalated cell-specific signaling cascade that couples
P2Y1 activation with NKCC1 inhibition.
In renal epithelial cells, P2Y receptors trigger diverse
signaling, including transient elevation of [Ca
2+]i, cAMP
production, activation of phospholipase C (PLC), phospho-
lipase A2 (PLA2), prostaglandin synthase, protein kinase C
(PKC), and protein kinase A (PKA) [19, 20]. We did not
observe any effect of extracellular Ca
2+ and intracellular
Ca
2+ chelator on NKCC inhibition in C11 cells [15, 21].
The inhibitory action of ATP is also preserved in the
presence of inhibitors of PLC, PLA2, and prostaglandin
synthase (U73122, AACOCF3, and indomethacin, respec-
tively) as well as under activation of adenylate cyclase with
forskolin and isoproterenol and inhibition of PKA with
H-89 [15, 21]. In C11 cells, NKCC inhibition was also
revealed in the presence of the PKC activator 4β-phorbol-
12-myristate-13-acetate (PMA). However, the same action
of PMA was also documented in C7 cells [15]. Moreover,
suppression of NKCC in ATP-treated cells was not affected
in the presence of PKC inhibitors (staurosporine and
calphostin C) and after downregulation of this enzyme by
chronic exposure to PMA [15, 21]. Viewed collectively,
these data strongly suggest that none of the above-listed
intermediates of the intracellular signaling cascade is
involved in the purinergic inhibition of NKCC [15, 21].
In contrast to the above-listed signals documented in
both principal- and intercalated-like cells, activation of P2Y
receptors resulted in phosphorylation of members of the
superfamily of mitogen-activated protein kinases (MAPK),
such as the extracellular signal-activated protein kinases
Erk1 and Erk2 and the Jun N-terminal kinase JNK1.
Compound PD98059, a potent Erk inhibitor, strongly
suppressed Erk1 and Erk2 phosphorylation in ATP-treated
C11 cells, but did not affect the inhibitory action of
ATP on NKCC activity [15, 21]. Considering these results,
we designed the present investigation to examine the
involvement of JNK and p38, a member of the stress-
activated protein kinases (SAPK), in P2Y-induced NKCC
inhibition.
Methods
Cell culture C11-MDCK cells were obtained from Dr. M.
Gekle (University of Würzburg, Germany) and cultured in
DMEM supplemented with 2.5 g/l sodium bicarbonate,
2 g/l hydroxyethylpiperazine ethanesulfonic acid (HEPES),
100 U/ml penicillin, 100 μg/ml streptomycin, and 10% fetal
bovine serum (Gibco Laboratories, Burlington, ON,
Canada).Thecellswerepassageduponreachingsubconfluent
density by treatment in Ca
2+-a n dM g
2+-free Dulbecco’s
phosphate-buffered saline (PBS) with 0.1% trypsin from
Sigma (St. Louis, MO, USA), then scraped from the flasks
with a rubber policeman. Dispersed cells were counted and
inoculated at 1.25×10
3 cells/cm
2.B e f o r ee x p e r i m e n t a t i o n ,
the cells were subjected to 24-h serum deprivation in the
presence of 0.1% bovine serum albumin (BSA).
NKCC measurement Serum-deprived cells seeded in 24-well
plates were washed twice with 2 ml of PBS and incubated for
30 min at 37°C in 1 ml of Cl
−-depleted medium A containing
140 mM Na gluconate, 5 mM K gluconate, 1 mM MgSO4,
1m MC a C l 2,5m MD-glucose, and 20 mM HEPES-Tris
(pH 7.4). After 30 min of Cl
− depletion, ATP and other test
184 Purinergic Signalling (2008) 4:183–191compounds were added at concentrations indicated in the
figure legends. In a major part of the experiments,
preincubation with ATP was limited to 30 min. Then, Cl
−-
depleted medium was replaced with 0.25 ml of medium B
containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2,1m M
CaCl2,5m MD-glucose, 20 mM HEPES-Tris (pH 7.4),
~1 μCi/ml
86Rb, and 50 μMo u a b a i n ± 1 0μMb u m e t a n i d e .
In 5 min,
86Rb uptake was terminated by the addition of 2 ml
of ice-cold medium C containing 100 mM MgCl2 and
10 mM HEPES-Tris buffer (pH 7.4). The cells were then
transferred on ice, washed 4 times with 2 ml of ice-cold
medium C, and lysed with 1 ml of a 1% SDS/4 mM
ethylenediaminetetraacetate (EDTA) mixture. The radioac-
tivity of the cell lysate was measured with a liquid
scintillation analyzer. The rate of
86Rb (K
+)i n f l u xw a s
calculated as V=A/amt where A was the radioactivity in the
sample (cpm), a was the specific radioactivity of
86Rb (K
+)
(cpm/nmol) in the incubation medium, m was the protein
content in the sample measured by modified Lowry’sm e t h o d
(mg), and t was the incubation time (min). NKCC activity
was estimated as the rate of ouabain-resistant, bumetanide-
sensitive
86Rb influx.
Western blotting C11 cells grown in 6-well plates were
incubated for 24 h in DMEM containing 0.1% BSA and
stimulated with ATP in Cl
−-depleted medium A. Then, the
cells were washed twice with ice-cold PBS and lysed in
200 μl of lysis buffer containing 20 mM Tris-HCl (pH 7.5),
150 mM NaCl, 10% glycerol, 1% Triton X-100, 0.1% SDS,
2 mM EDTA, 2 mM ethyleneglycoltetraacetic acid
(EGTA), 0.25% deoxycholate, 1 mM phenylmethylsulfonyl
fluoride, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 200 μM Na-
orthovanadate, and 1 mM NaF. The lysed cells were
scraped and centrifuged at 13,000 rpm for 5 min, and an
equal volume of clear lysates containing 20 μg of protein
was treated for 5 min at 95°C and applied on 10%
polyacrylamide gel, followed by electrophoresis and trans-
fer to Immobilon-P membranes (Millipore Corp., Bedford,
MA, USA). The membranes were washed with PBS
containing 0.05% Tween 20 (PBS-Tween) and 0.5% skim
milk, and incubated overnight at 4°C with antibodies. After
incubation, the membranes were washed 3 times with PBS-
Tween, incubated for 1 h with horseradish peroxidase-
conjugated antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), washed with PBS-Tween, and the protein
Fig. 1 Time dependence of NKCC inhibition in C11 cells triggered by the addition of 100 μMA T P
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cence detection kit (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) before exposure to X-ray film. Relative protein
content was quantified by the NIH image program.
Chemicals ATP, ouabain, bumetanide, forskolin, and PMA
wereobtainedfromSigma(St.Louis,MO,USA);anisomycin,
cell-permeable inhibitorsofJNK and p38kinases (compounds
SP600125 and SB202190, respectively) and their negative
controls [N
1-methyl-1,9-pyrazoloanthrone (MPA) and com-
pound SB202474, respectively] were purchased from
Calbiochem (La Jolla, CA, USA), and
86RbCl from Dupont
(Boston, MA, USA). Anti-phospho-SAPK/JNK (Thr183/
Tyr185) and anti- phospho-p38 (Thr180/tyr182) antibodies
were provided by Cell Signaling Technology Inc. (Hornby,
ON, Canada). Salts, D-glucose, and buffers were obtained
from Sigma (St. Louis, MO, USA) and Anachemia
(Montreal, QC, Canada).
Statistics The data were analyzed by Student’s t-test or the
t-test for dependent samples, as appropriate. Significance
was defined as p<0.05.
Results
In a previous study, we observed that 1-h preincubation of
C11 cells in Cl
−-depleted medium abolished the transient
activation of NKCC by ATP but sharply increased baseline
NKCC activity, allowing more precise estimation of the
Fig. 3 Representative blots revealing the effects of SP600125 (a),
MPA (b), SB202190 (c), and SB202474 (d) on JNK and p38
phosphorylation in C11 cells under control conditions and in the
presence of 100 μM ATP or 0.1 μM anisomycin. ATP and anisomycin
were added during the last 40 min of preincubation of cells in Cl
−-
depleted medium. Compounds SP600125, MPA, SB202190, and
SB202474 were added at the indicated concentrations 30 min before
ATP or anisomycin
Fig. 2 Representative blots showing the time-dependent action of 100 μM ATP, 10 μM forskolin, and 0.1 μM PMA on SAPK phosphorylation
in C11 cells
186 Purinergic Signalling (2008) 4:183–191inhibitory action of P2Y-induced signaling [13]. Consider-
ing these results, Cl
−-depleted cells were used in the present
experiments. Figure 1 shows that NKCC inhibition in Cl
−-
depleted cells occurred after a 10-min lag phase with
maximal attenuation of the carrier’s activity in 30–40 min
of ATP addition.
Incubation for 2 min with ATP was sufficient to induce
full-scale phosphorylation of JNK1 (p46) and p38 kinases
(Fig. 2). Phosphorylation of JNK2 in ATP-treated cells was
observed after a 5-min lag phase, and its time course was
negatively correlated with NKCC inhibition. In contrast to
sustained JNK phosphorylation, p38 phosphorylation was
partially normalized in 40 min of ATP addition. Activation
of adenylate cyclase with forskolin did not affect SAPK
phosphorylation. Very modest p38 and JNK phosphoryla-
tion was detected in 20 min of PMA addition. These results
show that neither PKA nor PKC is involved in SAPK
phosphorylation by ATP, which is consistent with the lack
of involvement of these serine-threonine kinases in inhibi-
tion of NKCC in ATP-treated C11 cells [15, 16, 21].
Consistent with numerous previous observations, anisomycin
sharply elevated SAPK phosphorylation (Fig. 3). Figure 4a
reveals that the action of anisomycin on JNK phosphory-
lation was lower than that of ATP; in contrast, anisomycin
was a more potent activator of p38 phosphorylation than
ATP. However, these differences were not statistically
significant. We observed that 40-min exposure to anisomycin
resulted in the inhibition of NKCC to about the same level
as was detected in ATP-treated cells (Fig. 4b).
With cell-free systems, it was demonstrated that several
newly synthesized cell-permeable compounds inhibited puri-
fiedorrecombinantJNKandp38withoutsignificantactionon
other protein kinases. Thus, compound SP600125 inhibited
r e c o m b i n a n tJ N K 1 - 3w i t ha nI C 50 of 0.05–0.20 μM,
whereas half-maximal inhibition of other members of the
MAPK superfamily, such as Erk and p38 as well as PKA and
cyclin-dependent kinases, was observed at concentrations
higher than 5 μM[ 22, 23]. It should be underlined that
SP600125 was a much less potent inhibitor of JNK in intact
cells. Indeed, inhibition of JNK in the anisomycin-treated
Fig. 4 Effect of ATP and anisomycin on JNK and p38 phosphory-
lation (a) and NKCC (b) in C11 cells. 100 μM ATP and 0.1 μM
anisomycin were added during the last 40 min of preincubation of cells
in Cl
−-depleted medium. Phosphoprotein content and NKCC activity
in the absence of ATP and anisomycin were taken as 1.0 and 100%,
respectively. Mean values from three (a) or four (b) independent
experiments are shown
Purinergic Signalling (2008) 4:183–191 187Fig. 6 Possible mechanisms of purinergic signaling in the regulation
of Cl
− secretion and acid-base homeostasis by principal (a) and
intercalated (b) cells from collecting ducts in vivo. 1 Cl
− channels,
2 H
+-ATPase, 3 anion exchange, PLC phospholipase C, IP3 inositol
1,4,5-triphosphate, COX cyclooxygenase, PGE1 prostaglandin E1,
CAMK (Ca
2++CaM)-dependent protein kinase, CA carbonic anhy-
drase, a.m. and b.m. apical and basolateral membranes, respectively.
For other abbreviations and more details, see text
Fig. 5 Effect of ATP, SP600125, and
SB202190 on NKCC activity in C11
cells; 100 μM ATP was added during
the last 40 min of preincubation of cells
in Cl
−-depleted medium. Compounds
SP600125 and SB202190 were added at
20 μM concentration 30 min before
ATP. NKCC activity in control cells was
taken as 100%. Mean±SE values from
experiments performed in quadruplicate
are shown
188 Purinergic Signalling (2008) 4:183–191KB-3 carcinoma cell line was detected after 1-h preincubation
with this compound at concentrations higher than 3 μM[ 23].
To decrease JNK phosphorylation by two- to threefold in
PMA-treated Jurkat cells, SP600125 should be added at a
concentration of 50 μM[ 22]. Surprisingly, we observed that
at a concentration of 20 μM SP600125 and SB202190, i.e.,
potent inhibitors of p38 SAPK in cell-free systems, increased
JNK and p38 phosphorylation to the level comparable with
their phosphorylation in the presence of ATP and anisomycin
(Fig. 3a and c). Moreover, like other potent activators of JNK
and p38 phosphorylation, such as ATP and anisomycin, both
SP600125 and SB202190 sharply decreased NKCC activity
in C11 cells (Fig. 5). In contrast, neither JNK/p38 phosphor-
ylation (Fig. 3b and d) nor NKCC activity in the presence
and absence of ATP (data not shown) was affected by the
inactive structural analogues of SP600125 and SB202190,
compounds MPA and SB202474, respectively.
Increased phospho-JNK and phospho-p38 levels in
SP600125- and SB202190-treated C11 cells, revealed in
our study, are in contrast with the inhibitory action on these
SAPK in cell-free systems [22, 23]. Indeed, the Calbiochem
catalogue notes that SP600125 and SB202190 inhibit
purified JNK and p38 with IC50 of 50 and 16 nM,
respectively. It should be underlined that both compounds
are ATP-competitive kinase inhibitors, and the data reported
were obtained at an ATP concentration of 5 μM, i.e., 1,000-
fold lower than the intracellular ATP concentration. For this
reason, in experiments with intact cells, these inhibitors are
used at much higher concentrations where diverse side
effects cannot be excluded. For more details, see [24].
Discussion
The data obtained in our study show that NKCC inhibition
in ATP-treated C11 cells is accompanied by activation of
JNK and/or p38. We also report here that activation of these
SAPK with three distinct stimuli, such as actinomycin,
SP600125, and SB202190, results in NKCC inhibition.
Additional experiments should be performed to establish
the causal relationship between SAPK activation and
NKCC inhibition. It should also be noted that the modest
inhibitory action of ATP on NKCC was preserved in the
presence of the above-listed activators of SAPK. This
observation suggests that the signaling cascade is not
limited to the activation of these kinases. Recent studies
have demonstrated that the with no lysine (K) kinase
member WNK4 downregulates NKCC1 via the STE20-
related kinase PASK interacting with the conserved domain
in the NKCC1 N-terminus [25–27]. The role of WNK
kinases in ATP-induced NKCC1 inhibition limited to
intercalated cells deserves further investigation.
Two questions should be answered to evaluate the role of
purinergic-dependent ion transporters in the regulation of
renal function in vivo. First, are concentrations of ATP and
other extracellular nucleosides sufficient for activation of
P2Y receptors on the apical and basolateral surfaces of
collecting duct epithelia? Second, what is the physiological
consequence of purinergic regulation of NKCC and other
ion transporters in principal and intercalated cells compris-
ing collecting ducts?
In peripheral blood, ectonucleotidases maintain circulat-
ing levels of ATP<10 nM [28], a concentration at which
renal P2 receptors with ID50(ATP)>1 μM[ 29] cannot be
activated. However, nucleosides can act in paracrine and
autocrine ways, reaching high extracellular concentrations
after sympathetic [30] and cholinergic [31] stimulation or
exposure to shear [32, 33], osmotic [34–36], and ischemic
stresses [33, 37–39]. Sympathetic innervation is probably
the major source of nucleosides for basolateral purinergic
receptors [38] whereas shear and osmotic stresses, occur-
ring in proximal tubules and the juxtaglomerular apparatus,
contribute to ATP release through the apical membrane in
tubular fluid [20, 40]. UsingchimericStaphylococcus aureus
protein A-luciferase bound to endogenous antigens on the
human airway epithelium, it was shown that hypotonic shock
leads to elevation of ATP concentration in surface fluid from
~0.001 to 1 μM[ 41]. Released ATP is rapidly metabolized
by ectoenzymes to adenosine. Importantly, modest elevation
of UTP [33] and adenosine [42] sharply increased ATP
release from MDCK cells, suggesting a positive feedback
loop. It is well documented that osmolality of tubular fluid in
collecting ducts varies from ~400 to 1,500 mOsm [43].
Baseline concentrations of ATP and other P2Y agonists in
collecting duct tubular fluid and their modulation by osmotic
perturbations remain unknown.
Both C7 and C11 cells, resembling principal and
intercalated cells, are highly abundant with P2Y1 and
P2Y2 receptors [13, 17]. In these cells, P2Y1 and P2Y2
receptors have been shown to mainly reside on the
basolateral and apical membranes, respectively [44]. Using
monolayers of C7 cells, it was noted that basolateral P2Y1
receptors activate Cl
− secretion via PLA2-PKA-mediated
activation of Cl
− channels [17]. Our studies demonstrated
that P2Y2 receptors contribute to Cl
− secretion via Ca
2+-
calmodulin-mediated activation of NKCC1 [14] (Fig. 6a).
Glanville and coworkers reported that in mouse collecting
ducts, basolateral NKCC possesses the same affinity for K
+
and NHþ
4 (K0.5 ~1.5 mM) [45]. Because bumetanide
markedly decreased the acidification rate in NH4Cl-treated
cells, they proposed a key role for NKCC1 in H
+ secretion
and NHþ
4 handling by intercalated cells. With intercalated-
like C11 cells, we observed that apical P2Y2 receptors
transiently activated NKCC1 via Ca
2+-calmodulin-mediated
signaling, whereas sustained activation of basolateral
Purinergic Signalling (2008) 4:183–191 189P2Y1 receptors inhibited this carrier [13]. The present data
suggest that NKCC1 inhibition in intercalated cells evoked
by P2Y1 agonists is caused by activation of SAPK
(Fig. 6b). Further studies should be performed to examine
the relative contribution of purinergic signaling in the
final adjustment of salt reabsorption and acid-base balance
by principal and intercalated cells in vivo as well as
the pathophysiological implications of these regulatory
pathways.
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